New drug combo shows promise in shrinking melanoma before surgery
NCT ID NCT04207086
First seen Jan 11, 2026 · Last updated May 07, 2026 · Updated 18 times
Summary
This study tests whether giving two drugs, pembrolizumab and lenvatinib, before surgery can help shrink tumors in people with stage III melanoma that can be removed. About 21 adults with resectable stage III melanoma will receive the drugs for 6 weeks, then have surgery to remove any remaining tumor. The main goal is to see how many patients have no cancer cells left in the removed tissue, and to understand how the drugs affect the immune system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA STAGE III are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Melanoma Institute Australia
North Sydney, New South Wales, 2060, Australia
Conditions
Explore the condition pages connected to this study.